ORIGINAL RESEARCH article

Front. Neurol.

Sec. Stroke

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1561329

This article is part of the Research TopicPathogenesis Insights and Innovative Strategies: Exploring Atherosclerosis and Cardiovascular DiseasesView all 3 articles

Unveiling the Dual Threat: Combined Elevated Triglyceride-Glucose Index and Intracranial Arterial Stenosis Burden for Enhanced Stroke Risk Stratification

Provisionally accepted
  • 1Shanghai Tenth People's Hospital, Tongji University, Shanghai, China
  • 2School of Medicine, Tongji University, Shanghai, Shanghai Municipality, China
  • 3Department of Neurology, Tongren Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

The final, formatted version of the article will be published soon.

AbstractBackground: The relationship between an elevated triglyceride-glucose index (TyG) combined with intracranial arterial stenosis (ICAS) and stroke recurrence remains incompletely understood. This study investigated how varying ICAS burdens influence the prognosis of ischemic stroke patients with different TyG levels.Methods: This prospective cohort study analyzed a consecutively enrolled population of 712 acute ischemic stroke patients, with intracranial atherosclerotic burden quantitatively evaluated via computed tomography angiography (CTA) or three-dimensional time-of-flight magnetic resonance angiography (MRA), and stenosis severity graded according to WASID criteria. Participants were categorized into four mutually exclusive subgroups based on TyG index quartiles and ICAS status (presence/absence). To investigate exposure-response gradients, further stratification incorporated both ICAS severity (no/mild [<50%], moderate [50-69%], or severe [70-99% or occlusion] stenosis) and vascular involvement (single vs. multiple affected arterial territories). The primary endpoint was defined as ischemic stroke recurrence within a standardized 90-day follow-up period. Cox proportional hazards models examined adjusted associations between TyG/ICAS status and outcomes, complemented by Kaplan-Meier curves with log-rank tests for time-to-event visualization. Mechanistic pathways were delineated through causal mediation analysis employing Quasi-Bayesian approximation (100 Monte Carlo simulations) to quantify mediating effects between metabolic dysfunction and cerebrovascular outcomes.​Conclusions: The synergistic combination of elevated TyG index and ICAS burden demonstrated superior prognostic value for 3-month stroke recurrence risk compared to either parameter independently, suggesting that concurrent assessment of insulin resistance (via TyG index) and vascular imaging biomarkers (via ICAS burden) may refine early risk stratification. This finding underscores the importance of integrating systemic metabolic dysfunction with structural cerebrovascular pathology to identify patients at heightened vulnerability during the critical post-stroke recovery window.

Keywords: Triglyceride glucose index, intracranial stenosis, Atherosclerosis, ischemic stroke, Stroke recurrence

Received: 15 Jan 2025; Accepted: 09 Jun 2025.

Copyright: © 2025 Liao, Meng and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Guilin Meng, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China
Xueyuan Liu, School of Medicine, Tongji University, Shanghai, Shanghai Municipality, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.